Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder	Recruiting	Not applicable	2026-06-22		NCT05937815

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Bordeaux	221

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HM CRCM pédiatrique	Marseille	France	1
AP-HP CRCM Robert debré	Paris	France	1
AP-PH Hopital Cochin service de pédiatrie	Paris	France	1
APHP Hopital Necker	Paris	France	1
CHRU de Lille CRCM Pédiatrique	Lille	France	1
CHU de Bordeaux - CRCM pédiatrique	Bordeaux	France	1
CHU de Grenoble Alpes CRCM pédiatrique	Grenoble	France	1
CHU de Limoges CRCM Limousin	Limoges	France	1
CHU de Montpellier	Montpellier	France	48
Chu de Nancy	Nancy	France	12
CHU de Nice	Nice	France	51
CHU de Rouen	Rouen	France	37
CHU de Toulouse	Toulouse	France	42
Fondation Ildys, Roscoff Centre Hélio Marin - Clinique "Mucoviscidose"	Roscoff	France	1
Hospices Civils de Lyon Service de pédiatrie, allergologie et mucoviscidose	Lyon	France	1